C1ORF96 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.259010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.043400E-01
Normal-vs-Stage2
8.794200E-02
Normal-vs-Stage3
1.402960E-01
Normal-vs-Stage4
3.003200E-01
Stage1-vs-Stage2
5.970000E-01
Stage1-vs-Stage3
7.072000E-02
Stage1-vs-Stage4
7.945200E-01
Stage2-vs-Stage3
1.96261999999559E-05
Stage2-vs-Stage4
9.461800E-01
Stage3-vs-Stage4
1.213350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.391430E-01
Normal-vs-AfricanAmerican
3.396600E-01
Normal-vs-Asian
2.292400E-02
Caucasian-vs-AfricanAmerican
6.242000E-01
Caucasian-vs-Asian
1.270150E-01
AfricanAmerican-vs-Asian
6.995800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.298160E-01
Normal-vs-Female
1.414790E-01
Male-vs-Female
9.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.204400E-01
Normal-vs-Age(41-60Yrs)
2.915600E-01
Normal-vs-Age(61-80Yrs)
1.005950E-01
Normal-vs-Age(81-100Yrs)
2.112600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.859000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.585200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.188100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.898300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.302700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.562200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.718000E-02
Normal-vs-Daily Drinker
3.244400E-02
Normal-vs-Weekly Drinker
1.544840E-01
Normal-vs-Occasional Drinker
5.051800E-01
Normal-vs-Social Drinker
3.954200E-01
Non Drinker-vs-Daily Drinker
6.633600E-01
Non Drinker-vs-Weekly Drinker
5.509600E-01
Non Drinker-vs-Occasional Drinker
1.821210E-01
Non Drinker-vs-Social Drinker
1.036760E-01
Daily Drinker-vs-Weekly Drinker
3.751800E-01
Daily Drinker-vs-Occasional Drinker
1.223590E-01
Daily Drinker-vs-Social Drinker
7.318400E-02
Weekly Drinker-vs-Occasional Drinker
4.453800E-01
Weekly Drinker-vs-Social Drinker
4.131600E-01
Occasional Drinker-vs-Social Drinker
9.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.716200E-01
Normal-vs-Grade 2
1.191640E-01
Normal-vs-Grade 3
1.177000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.311600E-01
Grade 1-vs-Grade 3
8.763800E-01
Grade 1-vs-Grade 4
2.716200E-01
Grade 2-vs-Grade 3
3.027400E-01
Grade 2-vs-Grade 4
1.191640E-01
Grade 3-vs-Grade 4
1.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.399800E-02
Normal-vs-NonDiabetic
1.140770E-01
Diabetic-vs-NonDiabetic
4.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.737790E-02
Normal-vs-NoPancreatitis
1.314810E-01
Pancreatitis-vs-NoPancreatitis
5.496100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.009600E-01
Normal-vs-N1
9.621800E-02
N0-vs-N1
6.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.202000E-02
Normal-vs-TP53-NonMutant
2.738600E-01
TP53-Mutant-vs-TP53-NonMutant
7.706100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
